KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.93

Totally laparoscopic versus laparoscopy-assisted distal gastrectomy: the KLASS-07: a randomized controlled trial.

Shin-Hoo Park, Chang-Min Lee, Hoon Hur, Jae-Seok Min, Seung Wan Ryu, Young-Gil Son, Hyun Dong Chae, Oh Jeong, Mi Ran Jung, Chang In Choi, Kyo Young Song, Han Hong Lee, Ho Goon Kim, Ye Seob Jee, Sun-Hwi Hwang, Moon-Soo Lee, Kwang Hee Kim, Sang Hyuk Seo, In Ho Jeong, Myoung Won Son, Chang Hyun Kim, Moon-Won Yoo, Sung Jin Oh, Jeong Goo Kim, Seong Ho Hwang, Sung Il Choi, Kyung Sook Yang, Hua Huang, Sungsoo Park

Int J Surg 110(8) 4810-4820

PMID38716987
PMCIDPMC11325945
DOI10.1097/JS9.0000000000001543
发表日期2024-05-08
入排依据:干预为非药物单独策略,未满足药物干预要求。
摘要

摘要

BACKGROUNDS: Strong evidence is lacking as no confirmatory randomized controlled trials (RCTs) have compared the efficacy of totally laparoscopic distal gastrectomy (TLDG) with laparoscopy-assisted distal gastrectomy (LADG). The authors performed an RCT to confirm if TLDG is different from LADG. METHODS: The KLASS-07 trial is a multi-centre, open-label, parallel-group, phase III, RCT of 442 patients with clinical stage I gastric cancer. Patients were enroled from 21 cancer care centres in South Korea between January 2018 and September 2020 and randomized to undergo TLDG or LADG using blocked randomization with a 1:1 allocation ratio, stratified by the participating investigators. Patients were treated through R0 resections by TLDG or LADG as the full analysis set of the KLASS-07 trial. The primary endpoint was morbidity within postoperative day 30, and the secondary endpoint was quality of life (QoL) for 1 year. This trial is registered at ClinicalTrials.gov (NCT03393182). RESULTS: Four hundred forty-two patients were randomized (222 to TLDG, 220 to LADG), and 422 patients were included in the pure analysis (213 and 209, respectively). The overall complication rate did not differ between the two groups (TLDG vs. LADG: 12.2% vs. 17.2%). However, TLDG provided less postoperative ileus and pulmonary complications than LADG (0.9% vs. 5.7%, P= 0.006; and 0.5% vs. 4.3%, P= 0.035, respectively). The QoL was better after TLDG than after LADG regarding emotional functioning at 6 months, pain at 3 months, anxiety at 3 and 6 months, and body image at 3 and 6 months (all P< 0.05). However, these QoL differences were resolved at 1 year. CONCLUSIONS: The KLASS-07 trial confirmed that TLDG is not different from LADG in terms of postoperative complications but has the advantages to reduce ileus and pulmonary complications. TLDG can be a good option to offer better QoL in terms of pain, body image, emotion, and anxiety at 3-6 months.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。